Japan, Aug. 31 -- BIOATLA LLC has got intellectual property rights for 'ANTI-CTLA4 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF.' Other related details are as follows:
Application Number: JP,2025-060295
Category (FI): A61K45/00,A61P37/04,A61K39/395@L,A61P35/00,A61K47/68,A61K31/537,A61K38/07,A61K31/704,A61K39/395@U,A61K31/5517,C07K16/28
Stage: Grant (IP right granted following substantive examination.)
Filing Date: April 1, 2025
Publication Date: July 15, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
